Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term Follow-Up of Patients Who Have Received an Autologous Antigen-Specific Chimeric Antigen Receptor T Regulatory Cell Therapy (CAR- Treg Therapy, TX200-TR101) in a Prior Clinical Study

NCT05987527 is registered in ClinicalTrials.gov with Sangamo Therapeutics as lead sponsor.

NCT NCT05987527
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05987527 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term Follow-Up of Patients Who Have Received an Autologous Antigen-Specific Chimeric Antigen Receptor T Regulatory Cell Therapy (CAR- Treg Therapy, TX200-TR101) in a Prior Clinical Study
Lead sponsor
Sangamo Therapeutics
Phase
Observational
Overall status
Active, not recruiting
Start date
August 15, 2023
Completion date
June 11, 2039
Enrollment
11 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease, kidney transplant rejection